Stanford Scientists Grow Human Cortical Organoids in Live Mice to Study Brain Disease

Inside a laboratory at Stanford University this week, ordinary-looking mice are scurrying around their enclosures, completely unaware that roughly half of their brains are made of human nerve cells. The rodents, genetically engineered to lack their own cerebral cortex, have been outfitted with lab-grown human brain tissue that has expanded to fill the void. The resulting "xenocortical" mice, detailed in a study published September 16 in the journal Nature, represent a massive leap in neurobiology: a living system where human neurons can grow, wire themselves together, and function inside an active body.[3][6]

For more than a decade, neuroscientist Sergiu Pașca and his Stanford team have been trying to solve a fundamental problem in brain research: the biggest barrier to understanding the human brain is the human around it. Scientists cannot ethically tinker with living human gray matter to see how conditions like schizophrenia or autism develop. While lab-grown "organoids"—tiny, three-dimensional clusters of neural tissue derived from human stem cells—have become increasingly sophisticated, they lack the blood supply and sensory inputs of a real body, limiting how much they can mature in a glass dish.[5][6]

In 2022, Pașca’s lab attempted to bridge this gap by transplanting human cortical organoids into the brains of newborn rats. While the human cells did integrate and respond to sensory inputs, they ran into a biological real estate problem. Human neurons develop much more slowly than rodent neurons, and the two systems were forced to compete for the same physical space, with the rodent cells ultimately outpacing the human tissue.[1][6]

To eliminate that competition, the Stanford researchers took a radical new approach. They genetically engineered a strain of mice to prevent the formation of the cerebral cortex—the brain's outer layer responsible for complex cognition and movement—as well as the hippocampus. When these "apallial" mice were just two days old, the team injected them with human cortical organoids, each containing roughly 100,000 human-derived cells, directly into the enlarged, fluid-filled cavities where the mouse cortex would normally be.[1][6]

The results were staggering. Without native mouse tissue crowding them out, the human grafts thrived. Within three months, the transplanted human tissue had expanded fivefold, ultimately accounting for more than 90 percent of the cortical tissue by volume in the xenocortical mice. The human cells vascularized, drawing in a blood supply, and began extending long-range nerve projections deep into the mouse nervous system, reaching as far as the cervical spinal cord.[1][5][6]

"The most important point is that these are still mice," Pașca explained to ScienceAlert. "They have a mouse nervous system, mouse sensory organs, and mouse subcortical structures. What is unusual is that most of the cortical tissue present in these animals is human-derived and that the human neurons grow, integrate, and form functional connections with the rest of the mouse nervous system."[5]

Remarkably, the integration allowed the human tissue to produce rare, specialized brain cells that are notoriously difficult to grow in vitro. The researchers observed the emergence of deep-layer projection neurons and cells resembling von Economo neurons—gigantic, cigar-shaped cells typically found in large-brained, highly social animals like great apes and humans. These specific neurons are known to be particularly vulnerable in frontotemporal dementia, a neurodegenerative disorder that often strikes in midlife.[1][5]

Despite missing their native cortex, the xenocortical mice performed surprisingly well. Behavioral testing conducted three to six months after the transplant surgery showed that the animals performed above chance on memory tests and behaved similarly to normal control mice, though they did exhibit some minor quirks, such as a slightly more cautious gait and mild working memory impairments. The fact that the mice functioned so normally suggests that the human cells were actively contributing to the animals' behavior and sensory processing.[1][5]

The true value of the xenocortical model lies in its potential to study human disease. In a proof-of-concept experiment, the researchers exposed the mice to five hours of low oxygen to mimic the kind of perinatal brain injury that can lead to cerebral palsy. The oxygen deprivation wreaked substantial damage on the human-originated cortical tissue, and the mice subsequently developed measurable motor deficits, proving that the model can successfully link cellular damage in human tissue to whole-animal behavioral changes.[1][5]

Creating animals with human brain tissue naturally raises profound ethical questions, particularly concerning whether such creatures could develop human-like consciousness or experience pain differently. To navigate these concerns, Stanford convened an independent panel of bioethicists, legal scholars, and patient advocates to oversee the experiments. The consensus remains that because the organoids are placed into an already developed mouse subcortical system, they do not form the specialized structures required for human-level cognition.[2][6]

As the technology matures, the Stanford team hopes to use the xenocortical mice to test targeted therapeutics for genetic conditions. "Every time you have somebody with a genetic mutation, you can either induce it in control cells, or you can take that patient's cells and transplant them," Pașca says. By providing a living, breathing environment for human brain cells to grow, researchers finally have a window into the intricate wiring of the mind—without ever having to open a human skull.[1][2]